What does Eliglustat (Cerdelga) do in plain English—and how does it work inside your body?
Eliglustat is an FDA-regulated Glucosylceramide Synthase Inhibitor (RxNorm RxCUI RXN-584680220-2775). Mechanistically, In oral-route clinical dosing (84 mg/1 Capsule), Eliglustat (manufactured/labeled by Genzyme Corporation; 58468-0220) executes glucosylceramide synthase inhibitor molecular modulation paired with routine metabolic and excretory disposition. [1][2].
When your doctor writes a prescription for Eliglustat (RxNorm RxCUI RXN-584680220-2775, also dispensed under brand names including Cerdelga), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, In oral-route clinical dosing (84 mg/1 Capsule), Eliglustat (manufactured/labeled by Genzyme Corporation; 58468-0220) executes glucosylceramide synthase inhibitor molecular modulation paired with routine metabolic and excretory disposition. [2].
Across real-world patient logs on dotMD (87% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Eliglustat tablet bottle and confirm with your pharmacist that it matches your prescribed strength (84 mg/1 Capsule, Longitudinal Eliglustat dosing interval tailored to tolerability).